Pfizer Inc. (PFE)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
39.52-0.11 (-0.28%)
As of 10:33AM EDT. Market open.
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 39.63 |
| Open | 39.71 |
| Bid | 39.40 x 2200 |
| Ask | 39.41 x 3200 |
| Day's Range | 39.39 - 39.84 |
| 52 Week Range | 29.99 - 43.08 |
| Volume | 4,538,148 |
| Avg. Volume | 27,618,190 |
| Market Cap | 220.449B |
| Beta (5Y Monthly) | 0.65 |
| PE Ratio (TTM) | 23.15 |
| EPS (TTM) | 1.71 |
| Earnings Date | Jul 26, 2021 - Jul 30, 2021 |
| Forward Dividend & Yield | 1.56 (3.90%) |
| Ex-Dividend Date | May 06, 2021 |
| 1y Target Est | 42.69 |
- Editor's PickYahoo Finance
Novavax CEO: Its COVID-19 vaccine will have biggest impact outside of US
Novavax (NVAX) will be able to pursue emergency use authorization following new information that shows its COVID-19 vaccine is 90% effective.
- Barrons.com
Novavax’s Covid Vaccine Is Real Competition for Pfizer and Moderna
The Covid vaccine from Novavax is practically as effective as those from Pfizer/BioNTech and Moderna—but easier to distribute. So why is the stock down?
- Barrons.com
AstraZeneca, Pfizer Vaccines Offer Strong Protection From Delta Variant
The highly contagious type of the virus that causes Covid-19 has become the dominant variety in the U.S., and is expected to spread in the U.S.
© 2021 Verizon Media. All rights reserved.
